Defunct Company
Total Trials
19
As Lead Sponsor
15
As Collaborator
4
Total Enrollment
664
NCT01972152
Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2013
Completion: Feb 28, 2014
NCT02081001
PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients
Start: Mar 31, 2014
Completion: Sep 30, 2014
NCT02081014
Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
Completion: Nov 30, 2014
NCT02423980
G-Pen™ for Hypoglycemia Rescue in T1D Patients
Start: Apr 30, 2015
Completion: Jun 30, 2015
NCT02411578
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
Role: Collaborator
Start: Sep 30, 2015
Completion: May 31, 2016
NCT02660242
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
Start: Jan 31, 2016
Completion: Feb 15, 2017
NCT02733588
Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
Start: Mar 31, 2016
Completion: Jun 1, 2017
NCT02937558
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Start: Oct 31, 2016
Completion: Oct 31, 2018
NCT02656069
Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics
Phase: Phase 3
Start: Mar 15, 2017
Completion: Sep 25, 2017
NCT03091673
Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
Start: Mar 27, 2017
Completion: Sep 27, 2017
NCT03255629
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia
Phase: Phase 1/2
Start: Sep 19, 2017
Completion: Aug 22, 2018
NCT03439072
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
Start: Jan 23, 2018
Completion: May 3, 2018
NCT03490942
Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
Start: Mar 15, 2018
Completion: Feb 10, 2020
NCT03424044
Three Way Crossover Closed Loop Study With Xeris Glucagon
Phase: Phase 1
Start: Mar 29, 2018
Completion: May 17, 2019
NCT03738865
G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes
Start: Sep 27, 2018
Completion: Apr 2, 2019
NCT03770637
Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery
Start: May 10, 2019
Completion: Feb 26, 2020
NCT03841526
Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
Start: Aug 22, 2019
Completion: Apr 2, 2020
NCT04074317
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
NCT05823012
Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
Start: May 15, 2023
Completion: Feb 22, 2024